3-Methylene-2,4-chromandione in situ trapping: introducing molecular diversity on 4-hydroxycoumarin

Adrien Montagut-Romans, Manon Boulven, Marc Lemaire and Florence Popowycz*
Equipe Chimie Organique et Bioorganique, Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, Institut National des Sciences Appliquées (INSA Lyon), Bâtiment Jules Verne, 20 Avenue Albert Einstein, F-69621 Villeurbanne Cedex, France. E-mail: florence.popowycz@insa-lyon.fr; Fax: +33 4 72 43 88 96; Tel: +33 4 72 43 82 21

Received 26th October 2015 , Accepted 25th November 2015

First published on 26th November 2015


Abstract

3-Methylene-2,4-chromandione trapped in a solid-state stable Mannich adduct, is released in solution. In the presence of different nucleophiles, this highly reactive intermediate allows the introduction of molecular diversity on C-3 position of 4-hydroxycoumarin.


The reactivity of ortho-quinone methides (o-QMs) has been largely exploited in natural products, total synthesis, medicinal chemistry and biochemistry. And yet, for a long time, o-QMs have been underused, mainly due to their transient nature.1 Quinone methides have been hardly ever isolated, due to fast reactions favored by rearomatization into phenol, acting as the driving force (Scheme 1, eqn (a)). Gardner2 detected their existence in 1963 by spectroscopy at −100 °C, even if more than fifty years before, in 1907, Fries got preliminary suspicion of the reality of such molecular species.3 Their high reactivity makes it attractive, in particular for multi-component reactions.4 Over the past years, they have regained a new interest for drug targeting or fluorescent probe.5 Biomimetic synthesis of Schefflone, a monoterpenoid was recently performed by oxidative trimerization of o-QM.6 A large spectrum for their biological activities was highlighted with the understanding of DNA alkylation, anti-tumoral or anti-bacterial properties and so on.7 As a notorious example, anti-diabetic Troglitazone was withdrawn in 2000 due to in vivo formation of o-QM metabolite displaying prejudicial secondary effects.8
image file: c5ra22440c-s1.tif
Scheme 1 Structural and reactivity analogy of ortho-quinone methide and 3-methylene-2,4-chromandione.

Recently, our laboratory reported an effective procedure for C-3 reductive alkylation of 4-hydroxycoumarin by a dehydrogenative oxidation of benzylic alcohols in the presence of RuCl2(PPh3)2 (5 mol%), KOH (0.2 eq.) in tertamyl alcohol under microwave irradiation at 140 °C in 2 hours.9 Supposed mechanism is described as a first step of activation of the alcoholic substrate by metallo-catalyzed dehydrogenative oxidation, followed by a Knoevenagel condensation/reduction sequence, under one pot conditions. The Knoevenagel adduct (3-methylene-2,4-chromandione) displaying similar structural analogy (Scheme 1, eqn (b)) with classical o-QM, is a versatile substrate for cycloaddition reactions.10 To a larger extent, 3-methylene-2,4-chromandione have been reported as in situ generated partner for multi-component reactions (MCRs), providing a powerful platform to access diversity as well as complexity. Following this strategy, pyranocoumarins were obtained by Knoevenagel-electrocyclic reaction starting from 4-hydroxycoumarin, an enal and an amine.11 o-QMs analogs have been involved in numerous cycloadditions ([4 + 2]12 or [4 + 1]13) and other multi-component or domino reactions.14 The common points of this strategy were to access the high added value molecules in a linear synthetic strategy.

The approach developed in the laboratory is to trap the 3-methylene-2,4-chromandione highly reactive intermediate in a solid-state stable Mannich adduct. This adduct in solution allows the formation of an equilibrium with the o-QM adduct which will react with various nucleophilic species (Scheme 2). Therefore, we decided to focus on an elegant approach to trap this intermediate by different methods including simple reduction methods. The methodology device should also limit the percentage of undesired DIM, which is often observable in all the synthesis reported in literature (Table 1).15


image file: c5ra22440c-s2.tif
Scheme 2 Equilibrium between Mannich adduct and methylene chromandione.
Table 1 Nature of nucleophilic amine

image file: c5ra22440c-u1.tif

Entry Amine Ratio
Product DIM
1 Pyrrolidine 100 0
2 Piperidine 90 1017
3 Dimethylamine 69 31
4 Morpholine 91 9
5 Diethylamine 60 40
6 Aniline 27 73
7 Isopropylamine 93 7
8 Proline 15 85


Preliminary study began with the choice of the amine partner involved in the Mannich reaction (Table 1). A set of primary and secondary amines were screened and pyrrolidine was the sole amine affording the desired Mannich adduct without any trace of dimer. Other amines (piperidine, morpholine and isopropylamine) led to 10% of undesired dimer adduct (entries 2, 4, 7). Dimethylamine, diethylamine (entries 3, 5) were less efficient with almost 40% of dimer. Aniline and proline (entries 6, 8) led to partial conversion in favour of expected product with in both cases, dimer as the major product. These results were almost in accordance with the nucleophilicity scale developed by Mayr and co-workers in 2009.16

Using the conditions outlined in entry 1 (Table 1), we tested the scope of this procedure with a range of aromatic aldehydes. The three-component reaction of 4-hydroxycoumarin, pyrrolidine and a set of benzaldehydes was effective in good to excellent yields, regarding the stoichiometric ratio of each partner (Table 2). No trace of bis-coumarin product was detected for compounds 1a–k. Dichloromethane was the best solvent, allowing the precipitation of the Mannich adduct at the end of the reaction and thus facilitating its isolation, by simple filtration (Table 2).

Table 2 Mannich reaction of 4-hydroxycoumarin (and analogs) with aldehydesa

image file: c5ra22440c-u2.tif

a Conditions: 4-hydroxycoumarin (1 mmol), aldehyde (1 mmol), pyrrolidine (1 mmol), CH2Cl2 (2 ml), rt, 2 h.
image file: c5ra22440c-u3.tif


The electronic nature of the substituent on aromatic ring did not affect the reaction and excellent yields were obtained for all substrates described in Table 2. Electronic effects (electron-donating group such as 1c, 1d or electron-withdrawing group for 1f, 1g) on aryl aldehyde do not affect the issue of the reaction. Halogen was also well tolerated (1e). Other substituted benzaldehydes such as 4-(pyridin-4-yl)benzaldehyde, 2,2-difluorobenzo[d][1,3]dioxole-5-carbaldehyde, 4-phenoxybenzaldehyde or 4-benzylbenzaldehyde were coupled with good to excellent yields (1h–k). Replacement of 4-hydroxycoumarin scaffold either by quinolone-2,4-diol (1l, 1m) or by 4-hydroxythiocoumarin (1n, 1o) resulted in similar yields.

To our delight, the reaction could be performed on 10 gram scale for compound 1a, our benchmark compound for the following studies. Three reactions were selected for evaluation of the reactivity of the Mannich adduct, as pointed out in Scheme 3: hydrogenation, Michael addition or tandem Michael addition–cyclization (Scheme 3). Hydrogenation allows the formation of linear C-3 alkylated compounds, which are not so obvious to obtain.18 Treating Mannich adduct 1a under H2 atmosphere (1 bar) in anhydrous ethanol with 10% Pd/C (5 mol%) afforded compound 2a quantitatively.


image file: c5ra22440c-s3.tif
Scheme 3 Overview of the reactivity of intermediate 1a.

Non-symmetrical dimer 3a was obtained in an excellent 97% yield by reaction of 1a with stoichiometric quantity of 4-hydroxythiocoumarin in acetonitrile at 50 °C during 3 hours. In this case, the mechanism reaction is supposed to be assimilated to Michael addition with nucleophilic 4-hydroxythiocoumarin reacting on o-QM liberated in solution. The last reaction explored is the MCR tandem reaction of Michael addition followed by cyclization to provide dihydropyrano[2,3-c]chromene skeleton. The reaction of 1a with malononitrile (1 eq.) in MeCN at 50 °C during 3 hours furnished derivative 4a in 98% yield. Thermal stability of compound 1a supplied important information on the equilibrium between Mannich adduct and o-QM. Heating a solution of 1a in MeCN [0.25 M] at 50 °C during 15 min only led to recovery of the starting material. After 15 min at 90 °C, a significant ratio of dimer could be quantified by 1H NMR at a level of 10%. The 1/9 mixture of dimer/1a was heating at 15 min at 110 °C leading to a displacement of the equilibrium in favour of a more important ratio of the dimer: 33% of DIM and 67% of substrate 1a. The stability experiments were run under microwave irradiation to speed up the kinetics and evaluate the stability of 1a. In regard with these observations, to limit the formation of the dimer, classic thermal activation was selected to the detriment of microwave irradiation.

All the Mannich adducts 1 (obtained in Table 2) were submitted to hydrogenation in conditions described in Scheme 3 to allow the formation of C-3 alkylated coumarins (Fig. 1). Excellent yields were obtained for most of the cases engaged in the reduction (11 successful reactions on 15 compounds) with isolation by simple filtration (no need to additional column chromatography for increasing the compounds purity).


image file: c5ra22440c-f1.tif
Fig. 1 Hydrogenation scopea. a Conditions: 1a, H2, Pd/C, EtOH, rt, 24 h.

As expected, derivatives 1e–g could not be reduced with good chemoselectivity and complete reduction of para substituent was observed. In the case of 1f, nitrile group was reduced into CH3 within 13% yield. Substrates with quinolone diol skeleton were reduced successfully into 2i and 2j, whereas compound 2k bearing 4-hydroxythiocoumarin, was obtained in poor yield of 23%, probably due to poisoning of the catalyst. Same observation was reported for the reduction for 1n and thus was not reported.

As in solution, Mannich adduct and o-QM intermediate are in equilibrium, any nucleophile could be selected to perform Michael addition and trap irreversibly the conjugated enone, with recovery of the aromaticity. Literature has reported many conditions for the formation of dicoumarols such as DIM. To our delight, no reference was found concerning the formation of unsymmetrical dimers. Pyrrolidinyl derivatives 1 were dissolved in acetonitrile, in the presence of a stoichiometric quantity of 4-hydroxythiocoumarin, at 50 °C (Table 3). In 3 hours, the reaction ran to completion in all cases with excellent isolated yields higher than 89%. Symmetrical DIM could be also obtained successfully in these conditions in 98% yield.

Table 3 Formation of non-symmetrical dimersa

image file: c5ra22440c-u4.tif

a Conditions: 1 (1 mmol), 4-hydroxythiocoumarin (1 mmol), CH3CN (2.5 ml), 50 °C, 3 h.
image file: c5ra22440c-u5.tif


We decided to apply our methodology to the synthesis of 2-amino-4H-pyrans prepared by a tandem Michael addition–cyclization sequence (Table 4). The access to functionalized 2-amino-3-cyano-4H-pyrans annulated heterocycle 4 has been already published by simple multi-component reaction between aldehydes, malononitriles and 4-hydroxycoumarin in the presence of a wide range of catalysts such as (NH4)2HPO4,19 proline,15 TBAB,20 meglumine,21 fermented Baker's yeast,22 ZnFe2O4,23 urea.24 Simple aqueous conditions25 were also efficient due to the hydrophobic effect as the driving force. Catalyst-free conditions in recyclable glycerol were recently developed.26 In a direct comparison to the above cited strategies, our approach is a stepwise process, based on the isolation of the o-QM intermediate and benefits from catalyst free conditions. With the optimized conditions, the scope and generality of this protocol was next examined by employing various o-QM intermediates 1.

Table 4 Tandem Michael addition/cyclizationa

image file: c5ra22440c-u6.tif

a Conditions: 1 (1 mmol), malononitrile (1 mmol), CH3CN (2.5 ml), 50 °C, 3 h.
image file: c5ra22440c-u7.tif


A family of eight new 2-amino-4H-pyran compounds 4 was synthesized using this protocol (Table 4). Good to excellent yields were obtained when 4-hydroxycoumarin skeleton was involved, whereas in the presence of 4-hydroxythiocoumarin, compound 4h was prepared with a poor yield of 25% due to problems in the solubility of the starting material, resulting in a low kinetics in this set of experimental conditions. In some cases such as 4b or 4e, the decrease of the yield could be also associated to the formation of the dimer present in significant quantities. As a perspective of these preliminary studies on the o-QM intermediates, we decided to study simple thiophenol nucleophiles and examine their reactivity towards o-QM intermediate 1 (Scheme 4).27


image file: c5ra22440c-s4.tif
Scheme 4 Introduction of simple nucleophiles.

Compounds 5a–c were obtained in moderate yield of 57–76% and conditions are under optimisation due do the problems of separation and the requirement of additional step of purification by column chromatography. Addition of acetophenone (4 eq.) was performed in a modest 50% yield under microwave activation (80 °C, 1 h).28

Conclusions

An efficient synthesis of 4-hydroxycoumarin derivatives in C-3 position has been developed by taking advantage of o-QM intermediate. A wide range of reagents H2, malononitrile, 4-hydroxythiocoumarin, thiophenols were used and broadened the scope. Due to the easily scalable step to generate derivatives 1, the challenging point is to generalize the second step of the reaction to any nucleophilic species. Aliphatic aldehydes were not tested in the first stage of the reaction and will deserve also some attention in the future.

Notes and references

  1. R. W. van de Water and T. R. R. Pettus, Tetrahedron, 2002, 58, 5367 CrossRef CAS.
  2. P. D. Gardner, H. S. Rafsanjani and L. Rand, J. Am. Chem. Soc., 1959, 81, 3364 CrossRef CAS.
  3. K. Fries and K. Kann, Justus Liebigs Ann. Chem., 1907, 353, 335 CrossRef CAS.
  4. (a) N. J. Willis and C. D. Bray, Chem.–Eur. J., 2012, 18, 9160 CrossRef CAS PubMed; (b) M. S. Singh, A. Nagaraju, N. Anand and S. Chowdhury, RSC Adv., 2014, 4, 55924 RSC.
  5. (a) S.-T. Huang, K.-N. Ting and K.-L. Wang, Anal. Chim. Acta, 2008, 620, 120 CrossRef CAS PubMed; (b) S. Gnaim and D. Shabat, Acc. Chem. Res., 2014, 47, 2970 CrossRef CAS PubMed.
  6. D. Liao, H. Li and X. Lei, Org. Lett., 2012, 14, 18 CrossRef CAS PubMed.
  7. (a) V.-S. Li, D. Choi, M.-S. Tang and H. Kohn, J. Am. Chem. Soc., 1996, 118, 3765 CrossRef CAS; (b) G. B. Evans, R. H. Furneaux, M. B. Gravestock, G. P. Lynch and G. K. Scott, Bioorg. Med. Chem., 1999, 7, 1953 CrossRef CAS PubMed; (c) S. B. Herzon and C. M. Woo, Nat. Prod. Rep., 2012, 29, 87 RSC.
  8. (a) K. Kassahun, P. G. Pearson, W. Tang, I. McIntosh, K. Leung, C. Elmore, D. Dean, R. Wang, G. Doss and T. A. Baillie, Chem. Res. Toxicol., 2001, 14, 62 CrossRef CAS PubMed; (b) V. A. Dixit and P. V. Bharatam, Chem. Res. Toxicol., 2011, 24, 1113 CrossRef CAS PubMed.
  9. A. Montagut-Romans, M. Boulven, M. Lemaire and F. Popowycz, New J. Chem., 2014, 1794 RSC.
  10. G. Appendino, G. Cravotto, L. Toma, R. Annunziata and G. Palmisano, J. Org. Chem., 1994, 59, 5556 CrossRef CAS.
  11. G. Cravotto, G. M. Nano and S. Tagliapietra, Synthesis, 2001, 49 CrossRef CAS.
  12. V. Nair, C. N. Jayan, K. V. Radhakrishnan, G. Anilkumar and N. P. Rath, Tetrahedron, 2001, 57, 5807 CrossRef CAS.
  13. (a) V. Nair, R. S. Menon, A. U. Vinod and S. Viji, Tetrahedron Lett., 2002, 43, 2293 CrossRef CAS; (b) A. Kumar, S. Srivastava and G. Gupta, Green Chem., 2012, 14, 3269 RSC.
  14. (a) G. Appendino, G. Cravotto, A. Minassi and G. Palmisano, Eur. J. Org. Chem., 2001, 3711 CrossRef CAS; (b) I. Yavari, M. Sabbaghan and Z. Hossaini, Synlett, 2008, 8, 1153 CrossRef; (c) S. Tu, C. Li, F. Shi, D. Zhou, Q. Shao, L. Cao and B. Jiang, Synthesis, 2008, 369 CrossRef CAS; (d) Y. Gu, J. Barrault and F. Jérôme, Adv. Synth. Catal., 2009, 351, 3269 CrossRef CAS; (e) J.-N. Tan, M. Li and Y. Gu, Green Chem., 2010, 12, 908 RSC; (f) X.-S. Wang, J. Zhou, K. Yang and M.-M. Zhang, Synth. Commun., 2010, 40, 3332 CrossRef CAS; (g) W. Ma, X. Wang, F. Yan, L. Wu and Y. Wang, Monatsh. Chem., 2011, 142, 163 CrossRef CAS; (h) M. Khoobi, A. Foroumadi, S. Emami, M. Safavi, G. Dehghan, B. H. Alizadeh, A. Ramazani, S. K. Ardestani and A. Shafiee, Chem. Biol. Drug Des., 2011, 78, 580 CrossRef CAS PubMed; (i) A. Kumar, M. Kumar, M. Kumar Gupta and L. P. Gupta, RSC Adv., 2012, 2, 8277 RSC; (j) S. M. Rajesh, S. Perumal, J. Carlos Menénedez, S. Pandian and R. Murugesan, Tetrahedron, 2012, 68, 5631 CrossRef CAS; (k) M. S. Singh, G. C. Nandi and S. Samai, Green Chem., 2012, 14, 447 RSC; (l) P. P. Ghosh, G. Pal, S. Paul and A. R. Das, Green Chem., 2012, 14, 2691 RSC; (m) C.-J. Lee, Y.-J. Jang, Z.-Z. Wu and W. Lin, Org. Lett., 2012, 14, 1906 CrossRef CAS PubMed; (n) M. G. Dekamin, M. Eslami and A. Maleki, Tetrahedron, 2013, 69, 1074 CrossRef CAS; (o) A. T. Khan, M. Lal and R. S. Basha, Synthesis, 2013, 406 CrossRef CAS; (p) S. Ahadi, M. Zolghadr, H. R. Khavasi and A. Bazgir, Org. Biomol. Chem., 2013, 11, 279 RSC.
  15. C. Wolfrum and F. Bohlmann, Liebigs Ann. Chem., 1989, 295 CrossRef CAS.
  16. T. Kanzian, T. A. Nigst, A. Maier, S. Pichl and H. Mayr, Eur. J. Org. Chem., 2009, 6379 CrossRef CAS.
  17. C. Mukhopadhyay, S. Rana and R. J. Butcher, Synth. Commun., 2012, 42, 3077 CrossRef CAS . Isolated yield of 78–81% when piperidine was used instead of pyrrolidine. No information if DIM was detected, but the yields are in accordance with the ratio measured in our experiments.
  18. General methods to access linear C-3 alkylated 4-hydroxycoumarins: (a) P. Bravo, C. Ticozzi and G. Cavicchio, Synthesis, 1985, 894 CrossRef CAS; (b) A. S. Kende, K. Koch and C. A. Smith, J. Am. Chem. Soc., 1988, 110, 2210 CrossRef CAS; (c) G. Cravotto, G. M. Nano, G. Palmisano and S. Tagliapietra, Synthesis, 2003, 1286 CAS; (d) M. Gebauer, Bioorg. Med. Chem., 2007, 15, 2414 CrossRef CAS PubMed; (e) R.-Y. Yang, D. Kizer, H. Wu, E. Volckova, X.-S. Miao, S. M. Ali, M. Tandon, R. E. Savage, T. C. K. Chan and M. A. Ashwell, Bioorg. Med. Chem., 2008, 16, 5635 CrossRef CAS PubMed; (f) C. R. Reddy, N. Kiranmai, K. Johny, M. Pendke and P. Naresh, Synthesis, 2009, 399 CrossRef CAS; (g) D. B. Ramachary and M. Kishor, Org. Biomol. Chem., 2010, 8, 2859 RSC; (h) G. Palmisano, F. Tibiletti, A. Penoni, F. Colombo, S. Tollari, D. Garella, S. Tagliapietra and G. Cravotto, Ultrason. Sonochem., 2011, 18, 652 CrossRef CAS PubMed; (i) Y.-J. Shue and S.-C. Yang, Tetrahedron Lett., 2012, 53, 1380 CrossRef CAS; (j) M. Baron, E. Métay, M. Lemaire and F. Popowycz, J. Org. Chem., 2012, 77, 3598 CrossRef CAS PubMed.
  19. S. Abdolmohammadi and S. Balalaie, Tetrahedron Lett., 2007, 48, 3299 CrossRef CAS.
  20. J. M. Khurana and S. Kumar, Tetrahedron Lett., 2009, 50, 4125 CrossRef CAS.
  21. R.-Y. Guo, Z.-M. An, L.-P. Mo, R.-Z. Wang, H.-X. Liu, S.-W. Wang and Z.-H. Zhang, ACS Comb. Sci., 2013, 15, 557 CrossRef CAS PubMed.
  22. M. Saha and A. K. Pal, Synth. Commun., 2013, 43, 1708 CrossRef CAS.
  23. P. Das, A. Dutta, A. Bhaumik and C. Mukhopadhyay, Green Chem., 2014, 16, 1426 RSC.
  24. G. Brahmachari and B. Banerjee, ACS Sustainable Chem. Eng., 2014, 2, 411 CrossRef CAS.
  25. A. Shaabani, S. Samadi and A. Rahmati, Synth. Commun., 2007, 37, 491 CrossRef CAS.
  26. H. R. Safaei, M. Shekouhy, S. Rahmanpur and A. Shirinfeshan, Green Chem., 2012, 14, 1696 RSC.
  27. (a) K. Nawaz, M. A. Munawar and M. Siddiq, J. Chem. Soc. Pak., 1991, 13, 272 CAS; (b) K. Tasneem and K. Z. Khan, Asian J. Chem., 2008, 20, 929 CAS.
  28. Analytical data were in accordance with those reported in literature: I. Manolov and N. Danchev, Arch. Pharm. Pharm. Med. Chem., 2003, 2, 83 CrossRef PubMed.

Footnote

Electronic supplementary information (ESI) available: Synthetic procedures, characterisation of compounds, NMR spectra. See DOI: 10.1039/c5ra22440c

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.